SCHEMBL6767472

SCHEMBL6767472

COc1cc2nc(N3CCCN(C(=O)N4CCOCC4)CC3)cc(N)c2c(-c2ccc(C(F)(F)F)cc2)c1OC

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.43
CNR2 P34972 1/20 0.42
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
USP2 O75604 1/20 0.37
PKM P14618 1/20 0.37
CFD P00746 1/20 0.37
ITGB2 P05107 1/20 0.36
ICAM1 P05362 1/20 0.36
ITGAL P20701 1/20 0.36
MCHR1 Q99705 1/20 0.36
KCNH2 Q12809 1/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6764933 0.93 CNR2 (0.39) AKR1C3CNR2KDM4EALDH1A1HPGD
SCHEMBL4603370 0.92 AKR1C3 (0.41) AKR1C3CNR2KDM4EALDH1A1HPGD
SCHEMBL6772466 0.91 AKR1C3 (0.46) AKR1C3CNR2KDM4EALDH1A1HPGD
SCHEMBL6771632 0.90 AKR1C3 (0.41) AKR1C3CNR2KDM4EALDH1A1HPGD
SCHEMBL6765566 0.90 AKR1C3 (0.45) AKR1C3CNR2KDM4EALDH1A1HPGD
SCHEMBL7012250 0.87 ALDH1A1 (0.41) AKR1C3CNR2KDM4EALDH1A1HPGD
SCHEMBL6771678 0.87 AKR1C3 (0.40) AKR1C3CNR2KDM4EALDH1A1HPGD
SCHEMBL6765104 0.87 KDM4E (0.40) AKR1C3CNR2KDM4EALDH1A1HPGD
SCHEMBL6767475 0.87 AKR1C3 (0.42) AKR1C3CNR2KDM4EALDH1A1HPGD
SCHEMBL7249486 0.86 AKR1C3 (0.40) AKR1C3CNR2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6750214-B2 PARTICULARLY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA COLLIS ALAN JOHN (US) 2004-06-15 US disclosed
US-6642242-B2 Antiproliferative agents to treat benign prostatic hyperplasia PFIZER INC. 2003-11-04 US disclosed
US-6103738-A Quinoline and quinazoline compounds useful in therapy PFIZER INC. (US) 2000-08-15 US disclosed
EP-0877734-B1 QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY PFIZER RES & DEV (IE) 2000-07-12 EP disclosed